|
|
|
Insider
Information: |
Bigham Michael |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
1,326,413 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$3,680,901 |
|
|
Total
Shares |
1,326,413 |
|
|
Total
Value |
$3,680,901 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
50.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Supernus Pharmaceuticals Inc |
SUPN |
Director |
2013-03-20 |
0 |
2013-03-22 |
25,000 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
Exec. Chairman of the ... |
2023-09-21 |
0 |
2015-06-30 |
1,301,413 |
Premium* |
|
Adamas Pharmaceuticals Inc |
ADMS |
Director |
2021-11-24 |
0 |
2020-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2018-02-05 |
4 |
AS |
$14.22 |
$56,880 |
D/D |
(4,000) |
123,680 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2017-02-06 |
4 |
AS |
$15.05 |
$75,469 |
D/D |
(5,000) |
95,000 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Director |
|
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Exec. Chairman of the Board |
|
2021-12-13 |
4 |
AS |
$4.42 |
$22,361 |
D/D |
(5,059) |
917,223 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2017-07-05 |
4 |
AS |
$23.58 |
$119,662 |
D/D |
(5,075) |
104,425 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Exec. Chairman of the Board |
|
2022-10-28 |
4 |
AS |
$3.47 |
$20,820 |
D/D |
(6,000) |
1,231,827 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2018-10-15 |
4 |
AS |
$8.96 |
$56,448 |
D/D |
(6,300) |
264,867 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2018-12-12 |
4 |
AS |
$6.76 |
$56,784 |
D/D |
(8,400) |
256,467 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Exec. Chairman of the Board |
|
2021-12-14 |
4 |
AS |
$4.37 |
$37,678 |
D/D |
(8,622) |
908,601 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2018-04-09 |
4 |
AS |
$12.70 |
$110,490 |
D/D |
(8,700) |
199,730 |
0 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Director |
|
2021-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Exec. Chairman of the Board |
|
2020-05-12 |
4 |
S |
$4.68 |
$57,330 |
D/D |
(12,250) |
542,167 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2018-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
271,167 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
14,500 |
109,500 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2013-03-22 |
4 |
B |
$5.65 |
$84,795 |
I/I |
15,000 |
25,000 |
2.1 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Exec. Chairman of the Board |
|
2022-12-21 |
4 |
AS |
$1.99 |
$31,343 |
D/D |
(15,750) |
1,209,702 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2018-10-03 |
4 |
AS |
$9.82 |
$160,194 |
D/D |
(16,313) |
257,167 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Exec. Chairman of the Board |
|
2021-12-15 |
4 |
AS |
$4.27 |
$76,087 |
D/D |
(17,819) |
890,782 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Exec. Chairman of the Board |
|
2020-12-11 |
4 |
AS |
$6.95 |
$127,442 |
D/D |
(18,337) |
572,580 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Exec. Chairman of the Board |
|
2022-12-12 |
4 |
AS |
$1.98 |
$38,578 |
D/D |
(19,484) |
1,212,343 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2013-03-20 |
4 |
B |
$5.17 |
$104,475 |
I/I |
20,000 |
10,000 |
2.1 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2016-06-23 |
4 |
B |
$13.45 |
$269,014 |
D/D |
20,000 |
100,000 |
2.81 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2018-06-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,050 |
236,417 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Chairman and CEO |
|
2018-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
21,750 |
208,430 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|